The γ3-subunit of the GABAA-receptor confers sensitivity to benzodiazepine receptor ligands  by Knoflach, F. et al.
Volume 293, number 1.2, 191-194 FEES 10419 
0 1991 Federation of European Biochemical Societies 00145793/91/%3.50 
November I99 1 
The y3-subunit of the GABA,-receptor confers sensitivity to 
benzodiazepine receptor ligands 
F. Knoflach’, Th. Rhyner’, M. Villa’, S. Kellenberger2, U. Drescher’, P. Malherbe3, E. Sigel’ 
and H. Miihler’ 
‘hsliture of Phartnacology Universily of Zfirich, Swirzerland ‘Instilute of Plluntutcology. Universily of Bern. Switzevhnd and 
‘Hofftnann-La Rode. Bade, Swikerland 
Received I7 September 1991; revised version received 3 October 1991 
The y3-subunit of the GABA,-receptor in rat brain has been identified by molecular cloning. When co-expressed with the aS- and @2-subunits 
in transfected cells a high potency for GA% (K, = 4.9 + I .2 pM; n?d a strong cooperativity in gating the channel (II = 1.9 t 0.2) was observed. 
The GABA response was potentiated in the presence of flunitrazepam and reduced by&CM. An analogous bi-directional modulation of the GABA 
response was observed with diazepam nnd DMCM as tested with the subunit combinations alg2y.t and a3@Zy3 expressed in Xcnoprts oocyles. 
Since the benzodiazepine receptor ligands were virtually inactive in the absence of the y3-subunit, ali tested with the a3/32- and a5/J2+ubunit 
combinations. the y3-subunit is a prcrcquisite for the benzodiazepine receptor sensitivity of the expressed GABA,-receptors. The y3-subunit could 
functionally replace the y2-subunit with regard to the bi-directional allosteric drug modulation. 
GABA,-receptor heterogeneity; Recombinant GABA,-receptor; y3-Subunit expression 
1. INTRODUCTION 2. MATERIALS AND METHODS 
The GABA,-receptor. which mediates the main inhi- 
bitory synaptic event in the CNS, is a gated chloride 
channel whose function is modulated by various clini- 
cally important drugs, in particular by barbiturates and 
ligands of the benzodiazepine receptor. Structurally, the 
GABA,-receptor is a hetero-oligomeric protein which 
is made up, in unknown stoichiometry, of the members 
of at least 5 different classes of subunits [l-4]. The 
yt-subunit is of special relevance for the pharmacology 
of the GABAA-receptor since this subunit, in combina- 
tion with CI- and /3+ubunits, is necessary to convey ben- 
zodiazepine receptor sensitivity to recombinant 
GABA,-receptors [5]. The pattern of expression of the 
y2-subunit, mapped in the brain by in situ hybridization 
histochemistry [5-71 and by immunocytochemistry [8], 
revealed a marked regional variation suggesting that 
subunits other than the yt-subunit may exist which con- 
fer the benzodiazepine receptor sensitivity to GABA,- 
receptors. We now show that the recently identified 
y3-subunit [9] is able to convey benzodiazepine receptor 
sensitivity to GABA,-receptors when co-expressed with 
c1- and P-subunits. 
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2. I. Molecrrlm cloning 
A cDNA-library in LZap II (Stratagene) from mRNA of newborn 
rat brain was screened [IO] with 2 oligonucleotidcs derived from the 
mouse y3-subunit sequence, bp6l-26and bp 1190-I 131[9]. Oneclone 
which hybridized to both probes was isolated and the cDNA-insert 
subcloned into the Bcrr~rHI site of a pBC expression vector [I 11. The 
y3-subunit cDNA was sequenced by the dideoxynucleotide chain- 
termination method [lo]. 
2.2. El~ctroplt~~siolugicol cmcri_vsis 
Recordings were performed 24 days after transfection of human 
embryonic kidney cells (ATCC CRL 1573, 293) with rat subunit 
cDNAs using the whole-cell configuration of the patch-clamp techni- 
que [I 21 at -30 mV as described previously [I 11. Expression of cRNAs 
and clectrophysiological analysis of drug effects on GABA currents 
expressed in Xenop~.s oocytcs were performed as described previously 
v31. 
3. RESULTS 
3.1. Cloning of’ rhe rut y3-subunit cDNA 
Since the a- and P-subunit cDNAs used in the present 
study were of rat origin [13,14], the y3-subunit cDNA 
was cloned from the same species by hybridization 
screening using 2 oligonucleotide probes from the 
mouse y3-subunit cDNA sequence [9]. A 1.9 kb rat 
cDNA clone, which hybridized with both probes, con- 
tai.:cd th: entire open reading frame displaying a nu- 
cleotide and protein sequence identity of 96 and 99%, 
respectively, to the mouse cDNA clone (Fig. 1). 
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Fig. I. cDNA scquencc and dcduccd amino acid sequcncc of the y3-subunit of the GABA,,-reccplor from ral brain. The putative signal scquoncc 
clcavagc site is indicated by an arrow; sites for N-linked glycosylation arc circled: the 2 cystcincs thought lo form R disullidc bridge arc boxed in: 
the proposed membr;tnc spanning domaina (MI-Ma) arc indicated by solid lines: thcamino acids which differ from those of the mouse y.l-subunir 
scqucncc [9] arc underlined. 
The dose-response curve for GABA was generated 
by applying increasing concentrations of GABA (1. 3. 
10. 30. IOOpM) for 2 s followed by a resting interval of 
1 min to mammalian cells transfected with the a5pZy3- 
subunit cDNAs (Fig. 2). The peak amplitudes of the 
GABA-induced currents were measured and fitted sepu- 
rately for each cell with the logistic equation 
In the presence of pentobarbital (50 PM) the GABA- 
induced current (3 PM GABA) was increased by 47 + 
13% in cells transfected with the a5P2y3-subunit 
cDNAs (II = 3). This potcntiation was not dependent on 
the presence of the y3-subunit. since the GABA-rc- 
sponsc was likewise potentiated (by 106%. II = 2) in cells 
co-transfected only with the a5- and the /32-subunit 
cDNAs. To determine whether the recombinant recep- 
tors expressed from the a5/?2y3 cDNAs displayed sensi- 
tivity to benzodiazcpinc receptor ligimds. the influence 
of the agonist flunitrazepam and the inverse agonist 
PCCM (methyl-4-cthyl-j3-carbolinc-3-carbo~yl~~tc) on 
the GABA-rcsponsc was tested. Drug concentrations 
wcrc chosen which wcrc previously shown to induct a 
maximum rcsponsc in recombinant rcccptors [ 1 I. 151. In 
the prcscncc of flunitrazcpam (1 ,uM) the current indu- 
ccd by GABA (3 PM) was potcntiatcd by 86 t 12% (n 
I/J,,;,, = I/{ I + (EC,&GABA})“} (1) 
whcrc ECS,, is the GABA concentration eliciting the half 
maximal current (l/2 I,,;,,) and I1 the Hill cocfficicnt. 
The results from 4 cxpcrimcnts yicldcd villucs of EC$, 
= 4.9 + 1.2 //M und N = I.9 & 0.2. 
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Fig. 2. GABA dose-response curve of cells cc-transfccted with the a5/32y3-subunit cDNAs. (A) Superimposed whole cell currents cvokcd by 
different GABA concentrations indicated by the numbers (L(M) at each trace. (B) Plot of the relative current amplitude as a function of increasing 
GABA concentrations. The points represent mean values with standard deviations from 4 cells. 
= 3) at the &5j?2y3-receptors. The inverse agonist 
PCCM (1 PM) decreased the current amplitude elicited 
by GABA (10 PM) by 29 k 5% (n = 5) in the u@2y3- 
combination (Fig. 3). Only negligible drug modulation 
was observed in the absence of the y3-subunit. When 
the a5b2-subunit cDNAs were expressed only a slight 
reduction of the GABA response was recorded in the 
presence of flunitrazepam (1 PM) or/KCM (1 PM), by 
8 2 5% (/I = 3) and 3 k 4% (12 = 4) respectively. 
The effects of agonists and inverse agonists were 
further tested on various other subunit combinations 
containing the y3-subunit in the Xerzoplcs oocyte expres- 
sion system and compared to subunit combinations 
containing the y2 instead of the y3-subunit (Fig. 4). In 
all combinations tested the y3-subunit could function- 
ally replace the y2-subunit with regard to the positive 
allosteric modulation of the GABA response by the 
benzodiazepine agonist diazepam and the negative al- 
losteric modulation by the inverse agonist DMCM 
(methyl-4-ethyl-6, 7-dimethoxy-@-carboline-3-carboxyl- 
ate) (Fig. 4). The depression of the GABA-gated current 
by DMCM was even more pronounced in the subunit 
A. GABA + f?rCCM B. GABA + FZP 
Fig. 3. Effects of flunitrazcpam and /KCM on GABA-induced cur- 
rents in cells co-transfcctcd with the aSP2y.7~subunit cDNAs. (A) The 
GAUA-induced current (IO PM. bottom tract) was rcduccd in the 
prcscncc ofDCCM (I PM. top tract).(B) Flunitrazcpam (FZP, I PM) 
potcntiatsd (bottom tract) the current clicitcd by GABA (3pM) alone 
(top trace), 
combinations containing y3 rather than 72. When a3j32 
was expressed in the absence of a y-subunit the stimula- 
tion by diazepam was reduced to 7 It: 1% (n = 5) as 
compared to rl 10% in the presence of either y2 or 73, 
while the inhibition by DMCM was lost completely 
(Fig. 4)Jn the combinations containing the y2-subunit 
(olIp2y2, a3bZy2) the effect of diazepam was somewhat 
smaller than found previously [ 131. 
4. DISCUSSION 
Three types of y-subunits of the GABA,-receptor 
have so far been cloned [5,9,16]. The yl-subunit has 
been reported to give rise to an untypical pharmacology 
in that the recombinant receptors displayed agonistic 
actions for PCCM when co-expressed with some dl- and 
t 
m diezepam 
150 
0 DMCM 
, a102r2 a18273 a3132 a38272 a3P273 I 
Fig. 4. Diazcpam and DMCM modulation ofdiffcrcnt subunit combi- 
nations cxprcsscd in X~~w~rr.v oocytes. Drug cffccts wcrc tcstcd at a 
GABA concentration eliciting about 10% of the maximal current 
amplitude in the rcspcctivc subunit combinations. Each value is an 
avcragc and SD of at Icast 7 cells originating from 2 diffcrcnt donor 
animals, cxccpt for the a$32 combination, for which 5 cells from a 
singlcdonorwcrcanalyscd. Thcdiazcpamconccntration was I PM; the 
DMCM concentration was 0. I PM and 0.3 /rM for the subunit com- 
binations comainiug a3 and ~1. rcspcctivcly. 
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p-subunit combinations [ 17,181. In contrast, the yZsub- 
unit conveyed a bi-directional modulation of the GABA 
response? being enhanced by an agonist and reduced by 
an inverse agonist of the benzodiazepine receptor [5]. 
This ability of the yZsubunit is shared by the y3-sub- 
unit [9] as now shown by an analysis of the a5JI2y3- 
subunit combination expressed in mammalian cells 
from rat subunit cDNAs. These findings are sub- 
stantiated by an investigation of additional subunit 
combinations (~1182~3, a3/32y3) expressed in Xc~opus 
oocytes, using a different benzodiazepine agonist and 
inverse agonist. As shown in transfected cells and in the 
oocyte expression system, neither benzodiazepine ago- 
nists nor inverse agonists appreciably modulate the 
GABA response when only the tx5/32 or the a3p3 sub- 
units, respectively, are co-expressed. This suggests that 
the y2- or y3-subunits are essential for a functional 
benzodiazepine receptor site in the triple subunit combi- 
nations. 
Both the y2- and y3-subunits support a strong coope- 
rativity of GABA in gating the channel. This is shown 
by the Hill coefficients of H = 1.9 -C 0.2 recorded for the 
cl5/?2y3-subunit combination and N = 1.7 k 0.1 report- 
ed earlier for the aS/32y2-combination [13]. However, 
the y2- and the y3-subunits may confer a different 
GABA-sensitivity to recombinant receptors. While a 
half-maximal response to GABA was obtained at a &- 
value of 4.9 k 1.2 ,uM for the a5B2y3-subunit combi- 
nation. a K, value of 14 f 3 ,uM was reported for the 
aSp2y2-subunit combination expressed in Xenopus oo- 
cytes [13]. Preliminary analysis of GABA dose-re- 
sponse curves of the subunit combinations alp2y2. 
ala2y3, a3B2y2 and a3P2y3 expressed in Xenoylrs oo- 
cytes indicates that y3 confers a 3-4-fold higher GABA- 
sensitivity to the recombinant GABA,-receptors than 
the y2-subunit (SK., unpublished observations). Thus. 
it is conceivable that the y3-subunit gives rise to recep- 
tars in situ with a higher sensitivity to GABA than those 
containing the y2-subunit. 
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